Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
HYDROmorphone
HYDROmorphone
- Formulary Narcotic - Oral Formulary
- Formulary Narcotic Liquids Formulary
VIEW MORE Opioid Agonists
Last updated: Nov. 24, 2025
- Black Box Warning: Injection: Respiratory depression risk; abuse potential
- Black Box Warning: Injection, High Potency: Opioid-tolerant patients only; Respiratory depression risk; abuse potential
- Black Box Warning: Oral, extended release: Opioid-tolerant patients only; overdose risk; abuse potential
- Black Box Warning: Oral, liquid & tablets: Abuse potential; respiratory depression; neonatal withdrawal; alcohol interaction
Exalgo medication guide
HYDROmorphone extended release tablets medication guide
Dilaudid dose-capping at 0.5 -- 1 mg for initial orders --> DILAUDID Dose Interchange Process
Convert EXALGO to immediate release DILAUDID tablets at same total daily dose, with dose divided into 4-6 times daily. Should be around-the-clock dosing.
Pharmacist information for *HIGH* dose Dilaudid PCA
Reviewed: June 24, 2010 (EXALGO)
REMS (Exalgo, HYDROmorphone ER tablet): View FDA REMS Info